Chem. Abstr. vol. 104 Entry 19600h (1986), Abstr. WO85-00368. |
Chem. Abstr. vol. 112 Entry 36465a (1990), Abstr WO89-05818. |
Chem. Abstr vol. 99 Entry 122919w (1983), Abstr EP 77460. |
Beauchamp et al., J. Med. Chem. vol. 28 pp. 982-987 (1985). |
Kha-Vang-Thaug et al. Chem. Abstr vol. 74 Entry 107635r (1971). |
Hans Bundgaard et al, "Allopurinol Prodrugs. IV Improved Rectal and Parenteral Delivery of Allopurinol Using the Prodrug Approach as Evaluated in Rabbits," International Journal of Pharmaceutics, vol. 27, (1985), pp. 71-80. |
Kha Vang Thang et al, "Inhibition De La Xanthine-Oxydase Par l'Allopurinol (1 H-5 H Dihydro-4,5 Pyrazolo [3,4-D] Pyrimidinone-4) (Etude Du Processus D'Oxydation et de L'Effet de l'Aminomethylation)," C.R. Acad. SC. Paris, vol. 272, Jan. 25, 1971, pp. 639-642. |
Roland K. Robins et al, "Purine Analog Inhibitors of Xanthine Oxidase--Structure Activity Relationship and Proposed Binding of the Molybdenum Cofactor," J. Heterocyclic Chem., vol. 22, (1985), pp. 601-634. |
Derwent Abstract of WO89-05818 (1989). |
B. R. Baker et al, "Irreversible Enzyme Inhibitors. CXXVI. Hydrocarbon Interaction with Xanthine Oxidase by Phenyl Substituents on Purines and Pyrazolo[3,4-D]Pyrimidines," J. Med. Chem., vol. 11, (1968), pp. 661-666. |
R. Stradi et al, "Synthetic Biological Response Modifiers; Part 1. Synthesis and Immunomodulatory Properties of Some N.sup.2 -(.omega.-(Hypoxanthin-9-Yl)Alkoxycarbonyl)-L-Arginines," Il Farmaco, vol. 45, (1990), pp. 39-47. |
Luis H. Toledo-Pere Yra et al, "A Study of the Immunosuppressive Effect of Allopurinol," Immunological Communications, vol. 9(1), (1980), pp. 7-11. |